KIR–HLA receptor‐ligand mismatch associated with a graft‐versus‐tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors
- 12 February 2009
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 53 (1) , 120-124
Abstract
Killer immunoglobulin‐like receptors (KIRs) on natural killer cells (NKs) recognize groups of human leukocyte antigen (HLA) class I alleles. Cells without an inhibitory HLA ligand may trigger NK activation. Reduced risk of relapse has been reported in malignant hematologic diseases after haploidentical transplantation when HLA ligands against the inhibitory KIRs present in the donor were absent in the recipient. We performed haploidentical transplant in three children with refractory solid tumors. Our results showed that beneficial antitumor effects could be observed in the presence of inhibitory KIR–HLA mismatch. These preliminary results suggest a possible association between disease control and NK cell alloreactivity. Pediatr Blood Cancer 2009;53:120–124.Keywords
This publication has 20 references indexed in Scilit:
- Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphomaBritish Journal of Cancer, 2007
- Haploidentical Stem Cell Transplantation in Patients with Pediatric Solid Tumors: Preliminary Results of a Pilot Study and Analysis of Graft versus Tumor EffectsKlinische Padiatrie, 2006
- Killer cell Ig‐like receptors ligand‐mismatched, alloreactive natural killer cells lyse primary solid tumorsCancer, 2006
- The Biology of Metastases in Pediatric SarcomasThe Cancer Journal, 2005
- Soft Tissue Sarcoma or Malignant Mesenchymal Tumors in the First Year of Life: Experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor CommitteeJournal of Clinical Oncology, 2005
- Allogeneic graft‐versus‐hepatoblastoma effectPediatric Blood & Cancer, 2005
- Graft-Versus–Ewing Sarcoma Effect and Long-Term Remission Induced by Haploidentical Stem-Cell Transplantation in a Patient With Relapse of Metastatic DiseaseJournal of Clinical Oncology, 2005
- Possible Allogeneic Graft-Versus-Tumor Effect in Childhood MelanomaJournal of Pediatric Hematology/Oncology, 2003
- T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantationBritish Journal of Haematology, 2003
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000